These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2834482)

  • 1. [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage].
    Dieval J; Morinière P; Roussel B; Bayrou B; Fournier A; Delobel J
    J Mal Vasc; 1987; 12 Suppl B():114-8. PubMed ID: 2834482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk].
    Steinbach G; Bosc C; Caraman PL; Azoulay E; Olry L; D'Azemar P; Chopin J
    Nephrologie; 1990; 11(1):17-21. PubMed ID: 2165223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
    Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low molecular weight heparin (CY 222) levels during hemodialysis sessions. Comparison of various chromogenic and chronometric methods. Problem of standardization].
    Roussel B; Dieval J; Bayrou B; Delobel J
    J Mal Vasc; 1987; 12 Suppl B():85-9. PubMed ID: 2834499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222.
    Ireland H; Lane DA; Flynn A; Pegrum AC; Curtis JR
    Thromb Haemost; 1988 Apr; 59(2):240-7. PubMed ID: 2838924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.
    Anastassiades E; Lane DA; Ireland H; Flynn A; Curtis JR
    Clin Nephrol; 1989 Dec; 32(6):290-6. PubMed ID: 2558829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin (CY-216) versus unfractionated heparin in chronic hemodialysis.
    Grau E; Sigüenza F; Maduell F; Linares M; Olaso MA; Martinez R; Caridad A
    Nephron; 1992; 62(1):13-7. PubMed ID: 1331831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of Fragmin (FR-860) in hemodialysis: multicenter cooperative study in Japan.
    Suzuki T; Ota K; Naganuma S; Koshikawa S; Hirasawa Y; Nakagawa S; Otsubo O; Akizawa T
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():46-54. PubMed ID: 1962904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of enoxaparine for anticoagulation in extracorporeal circulation in hemodialysis at high risk for hemorrhage].
    Dechelette E; Pouzol P; Jurkovitz C; Kuentz F; Polack B; Cuzin E; Woler M
    J Mal Vasc; 1987; 12 Suppl B():105-7. PubMed ID: 2834479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary study of the use of low-molecular weight heparin to prevent thrombotic risk].
    Delahousse B; Gruel Y; Moalic P; Foloppe P; Leclerc MH; Guerois C; Fimbel B; Leroy J
    J Mal Vasc; 1986; 11(4):330-7. PubMed ID: 3805895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulation in hemodialysis with a single dose of low molecular weight heparin].
    Vukusich A; Avalos C; Orellana G; Cifuentes C; Rivas J; Calderón F
    Rev Med Chil; 1995 Jun; 123(6):735-41. PubMed ID: 8525227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma exchange with very low molecular weight heparin CY 222. Biological profile and therapeutic value].
    Assogba U; Crespo B; Bayrou B; Binet JL; Rottembourg J
    Ann Med Interne (Paris); 1988; 139 Suppl 1():66-8. PubMed ID: 2854713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Appropriate dosage of unfraction heparin and low molecular weight heparin in hemodialysis patients].
    Xiao Q; Sun XF; Zhang D; Ma ZF; Wu MG; Wang H; Chen XM
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):187-91. PubMed ID: 20356555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin Fraxiparin in chronic hemodialysis. A dose-finding study.
    Morinière P; Dieval J; Bayrou B; Roussel B; Renaud H; Fournier A; Delobel J
    Blood Purif; 1989; 7(6):301-8. PubMed ID: 2558691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.
    Lane DA; Ireland H; Flynn A; Anastassiades E; Curtis JR
    Nephrol Dial Transplant; 1986; 1(3):179-87. PubMed ID: 2955253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.
    Brunet P; Simon N; Opris A; Faure V; Lorec-Penet AM; Portugal H; Dussol B; Berland Y
    Am J Kidney Dis; 2008 May; 51(5):789-95. PubMed ID: 18436089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of a low molecular weight heparin, CY 222, in the treatment of consumption coagulopathy].
    Audibert G; Lambert H; Toulemonde F; Alexandre P; Laprevote-Heully MC; Bollaert PE; Bauer P; Larcan A
    J Mal Vasc; 1987; 12 Suppl B():147-51. PubMed ID: 2834489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis.
    Stefoni S; Cianciolo G; Donati G; Colì L; La Manna G; Raimondi C; Dalmastri V; Orlandi V; D'Addio F
    Nephron; 2002; 92(3):589-600. PubMed ID: 12372942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis.
    Ryan KE; Lane DA; Flynn A; Shepperd J; Ireland HA; Curtis JR
    Thromb Haemost; 1991 Sep; 66(3):277-82. PubMed ID: 1745997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylactic and therapeutic use of a low molecular weight heparin fraction, CY 216].
    Roussi J; Houbouyan L; Tereschenko C; Alterescu R; François D; Toulemonde F; Goguel A
    J Mal Vasc; 1987; 12 Suppl B():123-7. PubMed ID: 2834483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.